As retatrutide is not yet approved in the UK, any product currently being marketed or sold as retatrutide outside of a regulated clinical trial has not been assessed for safety or quality by the Medicines and Healthcare products Regulatory Agency (MHRA), and its use carries significant risk
Specific to BPC-157 and TB-500, we just dont have the kind of high-quality human evidence that would allow me to directly or confidently recommend a specific product or a dose, or a route, or a treatment protocol for an orthopedic injury, and I tell them to be cautious. Splitter says he cautions his patients to be careful about peptides theyre getting online or from compounding pharmacies because they really dont know what theyre putting in their bodies
The ideal dosage for Sitagliptin depends on the patient
Other trials of GLP-1 RAs have also not yet provided a clear answer
For example, someone who took a medication before they knew it could be a problem, or reports collected through pregnancy and medication registries